Skip to content

K-Stock Briefing

https://kstockbriefing.com

  • About Us
  • News
    • News
  • IR Room
  • RESEARCH
  • Disclosures
    • Semiconductors
    • Bio & Healthcare
    • Defense
    • Shipbuilding
  • Toggle search form

[Disclosure] Celltrion (068270) KOSCOM Announces Market Measures for Stock Futures and Options Following Stock Dividend Decision

Posted on December 26, 2024July 16, 2026 By K-STOCK Editor No Comments on [Disclosure] Celltrion (068270) KOSCOM Announces Market Measures for Stock Futures and Options Following Stock Dividend Decision

Source Facts: Financial Supervisory Service Electronic Disclosure System (DART) / 2024-12-26

Disclosure Type: Market Measures for Stock Futures and Options

💡 3-Second Summary

Following Celltrion’s stock dividend decision, KOSCOM has announced administrative market measures adjusting the reference prices, trading multipliers, and exercise prices for Celltrion stock futures and options, effective December 27, 2024.

📊 1. [Key Disclosure Content & Key Metrics Summary]

  • Underlying Asset: Celltrion
  • Effective Date: December 27, 2024 (Friday)
  • Reason and Regulatory Basis: Celltrion’s stock dividend decision; applied under Articles 25, 30, 35, 62, and 70 of the Derivatives Market Business Regulations.
  • Major Market Measures:
    • 1. Adjustment of Futures Reference Prices: Effective December 27, 2024, the adjusted reference prices for all futures contracts listed on December 26, 2024, are established as follows:
      • January 2025 Contract: KRW 182,200
      • February 2025 Contract: KRW 182,900
      • March 2025 Contract: KRW 183,700
      • June 2025 Contract: KRW 185,100
      • September 2025 Contract: KRW 186,300
      • December 2025 Contract: KRW 187,400
    • Adjustment of Options Reference Prices: Applies to all options contracts listed on December 26, 2024; detailed figures are specified in the appended files.
    • 2. Adjustment of Trading Multiplier:
      • Target: Futures (January and February 2025 contracts with open interest as of the close of December 26, 2024), Options (all contracts listed on December 26, 2024)
      • Adjusted Trading Multiplier: 10.47225038
    • 3. Delisting of Futures Spread Contracts: Delists the following futures spread contracts due to differing trading multipliers between the near-month and far-month contracts.
      • January 2025 – March 2025 Spread
      • January 2025 – June 2025 Spread
      • January 2025 – September 2025 Spread
      • January 2025 – December 2025 Spread
    • 4. Option Exercise Prices and Special Listing:
      • Exercise Price Adjustment: Applies to all options contracts listed on December 26, 2024; adjusted exercise prices are specified in the appended files.
      • Special Listing: When the trading multiplier is adjusted, a new set of option contracts with a standard trading multiplier of 10 will be newly listed (9 or more contracts for the near-month to third near-month, and 3 or more contracts for the fourth to sixth near-month).

📈 2. [Expert View: What This Disclosure Means for Investors]

  • Verification of Derivatives Adjustment Schedule: This announcement serves to notify derivatives investors of the upcoming technical adjustments to contract specifications for Celltrion stock futures and options. Market participants must verify the adjusted reference prices applied starting on the effective date of December 27, 2024.
  • Changes in Contract Specifications: For the specified futures contract months (January and February 2025) and all options, the trading multiplier will be adjusted from the standard value to ‘10.47225038’. Investors should note this exact decimal multiplier when evaluating orders and outstanding positions.
  • Filing of Delisted and Special Listings: Investors should check the specific list of four futures spread contracts scheduled for delisting, and review the listing conditions for the new option contracts set with a standard multiplier of 10 using the appended documents.

📝 Editor’s Comment (by K-STOCK Editor)

This informational announcement by KOSCOM outlines the standard administrative adjustments applied to derivatives contracts following Celltrion’s stock dividend resolution. These technical measures serve to mathematically calibrate the futures and options contract specifications to align with the adjusted cash market metrics resulting from the stock dividend decision.

The primary focus for market participants is the exact effective date and the finalized metrics provided in the filing. Starting December 27, 2024, the adjusted reference prices across contract months (such as KRW 182,200 for the January 2025 contract) and the modified trading multiplier of 10.47225038 will officially take effect under the specified derivatives regulations.

Consequently, investors should verify that the reference prices and contract multiplier adjustments are updated as scheduled on December 27, and consult KOSCOM’s detailed appendices to verify the exact specifications of the newly listed options contracts.

📢 Disclaimer & Source Information

Source: This content has been newly structured and written based on official disclosure data submitted to the Financial Supervisory Service’s Electronic Disclosure System (DART).

Investment Risk Warning: This content is provided for informational and linguistic reference purposes only. Under no circumstances does it constitute financial advice or a recommendation to buy or sell specific stocks. All investment decisions and financial liabilities rest solely with the investor.

Contact: For compliance inquiries or copyright-related requests, please contact ksb220805@gmail.com.

🐂
BULLS
VS
🐻
BEARS

🔥 Bulls vs Bears, drop your analysis in the comments!

Disclosures, Bio & Healthcare

Post navigation

Previous Post: [Disclosure] LEENO Industrial (058470) Finalizes Year-End Cash Dividend at ₩3,000/Share (Total ₩45.5B), Amends Dividend Yield to 1.5% in Corrected Filing
Next Post: [Disclosure] Hanwha Aerospace (012450) Extends Disclosure Postponement for Supply Contract to April 30, 2025

Related Posts

[Disclosure] SAMSUNG BIOLOGICS(207940) Cleared of Alleged Accounting Rule Violations in Second-Instance Appellate Court Verdict Disclosures
[Disclosure] SK square (402340) Subsidiary SK Hynix Approves Historic 9.4T KRW Mega-CAPEX for New Yongin AI Semiconductor Fab! Semiconductors
[Disclosure] Hanwha Ocean (042660) Amends MCS Plant Contract with Affiliate Hanwha Aerospace to Adjust Value and Period Disclosures
[Disclosure] Celltrion Submits European Phase 3 Clinical Trial Application (Part 1) for CT-P44 (Darzalex Biosimilar) (068270) Disclosures
[Disclosure] Alteogen (196170) to Hold Overseas IR Hosted by Bank of America, Targeting Global Institutional Investors Disclosures
[Disclosure] SK hynix (000660) Sets Q3 24 Earnings Call for October 24: Global Corporate IR Webcast Announced Semiconductors

Leave a Reply Cancel reply

You must be logged in to post a comment.

  • [Disclosure] Alteogen (196170) Establishes August 6 as Record Date for Bonus Issue Share AllotmentJuly 16, 2026
  • [Disclosure] Alteogen (196170) Announces Trading Suspension and Resumption Schedule for Stock Futures and OptionsJuly 16, 2026
  • [Disclosure] Alteogen (196170) Temporarily Suspends Plans for Relisting on the KOSPI MarketJuly 16, 2026
  • [Disclosure] Alteogen (196170) Announces Temporary Trading Suspension on July 16 Due to Bonus Issue DecisionJuly 16, 2026
  • [Disclosure] Alteogen (196170) Decides on Bonus Issue of 0.3 Shares per 1 Common and Preferred ShareJuly 16, 2026

Copyright © 2026 K-Stock Briefing.

Powered by PressBook Grid Dark theme